Metraipolis › archive › dc_40bd8cedcce0

Factors associated with early receipt of COVID-19 vaccination and adherence to second dose in the Veterans Affairs healthcare system — Europe PMC PMID:34851970

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34851970
DOI
10.1371/journal.pone.0259696
License (as archived)
CC0-1.0
Archived
2026-11-01T06:05:17.425Z
SHA-256 of the archived text
3e09c65edc7fefe8fc9a6c5837ced8a6cfd29dc7a06ca550954f19f191cf7a19
Stable URL of this page
https://metraipolis.com/documento/dc_40bd8cedcce0

How to cite

Factors associated with early receipt of COVID-19 vaccination and adherence to second dose in the Veterans Affairs healthcare system — Europe PMC PMID:34851970 — Europe PMC (en), https://europepmc.org/article/MED/34851970 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_40bd8cedcce0 (Metraipolis archive dc_40bd8cedcce0, sha256 3e09c65edc7fefe8fc9a6c5837ced8a6cfd29dc7a06ca550954f19f191cf7a19)
BibTeX
@misc{dc40bd8cedcce0,
  title = {Factors associated with early receipt of COVID-19 vaccination and adherence to second dose in the Veterans Affairs healthcare system — Europe PMC PMID:34851970},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34851970},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_40bd8cedcce0; sha256 3e09c65edc7fefe8fc9a6c5837ced8a6cfd29dc7a06ca550954f19f191cf7a19},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34851970. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: We aimed to determine factors independently associated with early COVID-19 vaccination and adherence to two-dose regimens. Methods: Among persons receiving care in the Veterans Affairs (VA) healthcare system (n = 5,766,638), we identified those who received at least one dose of COVID-19 vaccination through the VA, during the first ~3months following emergency use authorization, from December 11, 2020 to March 9, 2021 (n = 1,569,099, or 27.2%, including 880,200 (56.1%) Moderna, 676,279 (43.1%) Pfizer-BioNTech and 12,620 (0.8%) Janssen vaccines). Results: Follow-up for receipt of vaccination began on December 11, 2020. After adjustment for baseline characteristics ascertained as of December 11, 2020, factors significantly associated with vaccination included older age, higher comorbidity burden, higher body mass index category, Black (vs. White) race (adjusted hazard ratio [AHR] 1.19, 95% CI 1.19-1.20), Hispanic (vs. non-Hispanic) ethnicity (AHR 1.12, 95% CI 1.11-1.13), urban (vs. rural) residence (AHR 1.31, 95% CI 1.31-1.31), and geographical region, while AI/AN race (vs. White), was associated with lower vaccination rate (AHR 0.85, 95% CI 0.84-0.87). Among persons who received both doses of Moderna or Pfizer-BioNTech vaccines, 95.3% received the second dose within ±4 days of the recommended date. Among persons who received the first vaccine dose, only 3.2% did not receive the second dose within 42 days for Pfizer versus 4.0% for Moderna (p<0.001). Factors independently associated with higher likelihood of missing the second dose included younger age (10.83% in 18-50 yo vs. 2.72% in 70-75 yo), AI/AN race, female sex, rural location, geographical region and prior positive test for SARS-CoV-2. Conclusions: We identified sociodemographic and clinical factors that may be used to target vaccination efforts and to further improve adherence to second vaccine dosing.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-12-01).
Identificativi: PMID 34851970 · PMCID PMC8635372 · DOI 10.1371/journal.pone.0259696.
Descrittori MeSH principali: Drug Monitoring.
Pagina: https://europepmc.org/article/MED/34851970 — https://doi.org/10.1371/journal.pone.0259696. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-01T05:57:02.520Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.